SO
TNGX icon

STRS Ohio’s Tango Therapeutics TNGX Stock Holding History

STRS Ohio’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-15,900
Closed -$126K – 2095
2024
Q1 		$126K Sell
15,900
-2,300
-13% -$24.7K ﹤0.01% 1647
2023
Q4 		$180K Sell
18,200
-5,700
-24% -$49.5K ﹤0.01% 1596
2023
Q3 		$269K Buy
23,900
+10,000
+72% +$61K ﹤0.01% 1481
2023
Q2 		$46K Buy
13,900
+3,000
+28% +$10.8K ﹤0.01% 1819
2023
Q1 		$43K Hold
10,900
– – ﹤0.01% 1801
2022
Q4 		$79K Hold
10,900
– – ﹤0.01% 1754
2022
Q3 		$39K Hold
10,900
– – ﹤0.01% 1858
2022
Q2 		$49K Buy
+10,900
New +$66K ﹤0.01% 1860

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

STRS Ohio's TNGX Position: Q2 2024 in Review

STRS Ohio sold out of Tango Therapeutics (TNGX) in Q2 2024, closing a stake of 15,900 shares — an estimated $126K sold.

STRS Ohio first reported a position in TNGX in Q2 2022 and held it in 8 quarters. The position peaked at $269K in Q3 2023. 119 funds tracked by Wall St. Rank hold TNGX as of Q2 2024.

  • STRS Ohio reported no remaining Tango Therapeutics position as of Q2 2024 after selling out during the quarter.
  • STRS Ohio sold 15,900 Tango Therapeutics shares in Q2 2024, an estimated $126K.
  • STRS Ohio first reported a position in Tango Therapeutics in Q2 2022 and held it in 8 quarters.
  • STRS Ohio's Tango Therapeutics position peaked at $269K in Q3 2023.
  • 119 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2024.

Based on STRS Ohio's 13F filing for Q2 2024, filed 5 Aug 2024.